March 19 (Reuters) - Jasper Therapeutics Inc JSPR.O:
JASPER THERAPEUTICS INC - ON MAR 14, TERMINATED CANTOR SALES AGREEMENT DATED NOV 10, 2022
Source text: [ID:n0001213900-25-025123]
Further company coverage: JSPR.O
((Reuters.Briefs@thomsonreuters.com;))